What does Alector, Inc. (ALEC) do?

Alector, Inc. (ALEC) is a publicly traded company in the Healthcare sector.

What sector does ALEC operate in?

Alector, Inc. operates in the Healthcare, specifically within the Biotech industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find ALEC earnings analysis?

AlphaOS publishes an earnings intelligence page for Alector, Inc. (ALEC) covering results, guidance context, and AI-assisted analysis. See /stocks/ALEC/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

ALEC

Alector, Inc.

Healthcare · Biotech

$1.95Sep 25, 2026

AI confidence 70% · refreshes every 15s during session

Investment Snapshot

Weak evidence · 1 source

Why it matters

Alector, Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -58% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -58% YoY in Q2 FY2026

Pipeline evidence · 1d ago

ALEC's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on ALEC.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full ALEC earnings analysis

Reported figures for Alector, Inc. — research only, not investment advice.

Revenue YoY: -57.8%

Latest Intelligence

Updated September 28, 2026

What happened recently for Alector, Inc. (ALEC) — events, not interpretation.

Event: Reported Q2 2026 revenue -58% YoY.
Also: Last session September 25, 2026 at $1.95.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Alector, Inc. (ALEC)

Healthcare · Biotech

Investment Snapshot above is the primary AlphaOS analysis for Alector, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Biotech
Market cap:: $217.73M
Revenue:: $3.32M

ALEC earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Alector, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related & Connected

Biological Products, (No Diagnostic Substances)90% confidencerelated

Connected companies and research pages from the AlphaOS knowledge graph.